SPY301.74-1.23 -0.41%
DIA253.00-1.36 -0.53%
IXIC9,363.92-5.07 -0.05%

Assembly Biosciences Q1 EPS $(0.760) Beats $(0.980) Estimate, Sales $4.100M Beat $3.820M Estimate

Assembly Biosciences (NASDAQ:ASMB) reported quarterly losses of $(0.760) per share which beat the analyst consensus estimate of $(0.980) by 22.45 percent. This is a 27.62 percent increase over losses of $(1.050) per

Benzinga · 05/07/2020 20:55

Assembly Biosciences (NASDAQ:ASMB) reported quarterly losses of $(0.760) per share which beat the analyst consensus estimate of $(0.980) by 22.45 percent. This is a 27.62 percent increase over losses of $(1.050) per share from the same period last year. The company reported quarterly sales of $4.100 million which beat the analyst consensus estimate of $3.820 million by 7.33 percent. This is a 5.53 percent increase over sales of $3.885 million the same period last year.